{"task_id": "84af04fe833845a0", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 329/905)", "text": "ey function \nif proteinuria controlled to <1g/24h.\n\n--- Page 335 ---\n321\nRenal medicine\nFig 7.14 A polycystic kidney (left) compared with a normal-sized kidney (right). \nThe progressive increase in size can lead to abdominal discomfort. There may be \nhaemorrhage into a cyst causing haematuria, or infection.\nCourtesy of the PKD Foundation.\nCystinuria\n1 in 17 000. Autosomal recessive defect prevents reabsorption of cystine and dibasic \namino acids in proximal tubule. Leads to cystinuria and cystine stone formation. \nTreatment: diet, \ue000\ufb02 uid intake, and urine alkalinization. Current drugs which increase \ncystine solubility have adverse side-eff ect pro\ufb01 les.\nCystinosis\n1 in 100 000\u2013200 000. Autosomal recessive. Lysosomal storage disorder with accumula-\ntion of cystine. In nephropathic forms causes proximal tubule dysfunction, Fanconi \nsyndrome (p316), and progressive renal impairment. Also visual impairment, myopathy, \nhypothyroidism. Oral cysteamine \ue001intralysosomal cystine, and delays ESRF, but is poorly \ntolerated (GI symptoms, skin deposits, fever, seizures).", "text_length": 1074, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 329/905)", "type": "chunk", "chunk_index": 328, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.733171", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.735182", "status": "complete", "chunks_added": 1}